Sugi Predict

Sugi Predict / Compounds / SCHEMBL4071409

SCHEMBL4071409

SCHEMBL4071409

COC(=O)c1ccc(Cl)cc1S

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.64
▸ NR4A2 P43354 2/20 0.51
▸ SLC6A4 P31645 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ MAPT P10636 3/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ NFKB2 Q00653 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ PDK2 Q15119 1/20 0.46
▸ PDK4 Q16654 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10373452 0.85 ABL1 (0.59) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL6100118 0.82 ABL1 (0.70) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL608814 0.81 ABL1 (0.68) ABL1NR4A2MAPTNPC1RAB9A
SCHEMBL3304476 0.81 MAPK1 (0.55) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL32662867 0.79 CA12 (0.67) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL1016173 0.79 ABL1 (0.66) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL17080159 0.79 KDM4E (0.62) MAPTSMN1; SMN2ALDH1A1CA12CA1
SCHEMBL1058422 0.79 CA12 (0.67) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL804379 0.79 NR4A2 (0.50) ABL1NR4A2MAPTL3MBTL1ALDH1A1
SCHEMBL23035401 0.78 ABL1 (0.64) ABL1NR4A2SLC6A4SLC6A3RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022015624-A1 SUBSTITUTED DIHYDROPYRAZINEDIONES AS MODULATORS OF THE NMDA RECEPTOR SCHRÖDINGER, INC. (US) 2022-01-20 — — WO disclosed
WO-2022015624-A1 SUBSTITUTED DIHYDROPYRAZINEDIONES AS MODULATORS OF THE NMDA RECEPTOR SCHRÖDINGER, INC. (US) 2022-01-20 — — WO disclosed
US-20100234363-A1 HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 DATA-HYDROXYSTEROID DEHYDROGENASE INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-09-16 — — US disclosed
US-20100234363-A1 HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 DATA-HYDROXYSTEROID DEHYDROGENASE INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-09-16 — — US disclosed
EP-2208728-A1 HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 -HYDROXYSTEROID DEHYDROGENASE Institute Of Medicinal Molecular Design, Inc. (JP) 2010-07-21 — — EP disclosed
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives H. LUNDBECK A/S (DK) 2009-07-30 — — US disclosed
US-7534791-B2 Benzo[b]furane and benzo[b]thiophene derivatives H. LUNDBECK A/S (DK) 2009-05-19 — — US disclosed
US-20090029975-A1 1,3-BENZOTHIAZINONE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-29 — — US disclosed
US-20090029975-A1 1,3-BENZOTHIAZINONE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-29 — — US disclosed
US-20090029975-A1 1,3-BENZOTHIAZINONE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-29 — — US disclosed
US-6583089-B1 Pre- and postemergence herbicides such as (5,5-dimethyl-1,3-dioxocyclohex-2yl)(6-methoxy-3a,4-dihydro-3H -chromeno(4,3c) isoxazolin-9-yl)methanone, formed by acylation and rearranging in the presence of catalysts BASF AKTIENGESELLSCHAFT (DE) 2003-06-24 — — US disclosed
CN-1358186-A Tricyclic benzoylcylohexanedione derivatives BASF AG (DE) 2002-07-10 — — CN disclosed
EP-0850218-A1 HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-07-01 — — EP disclosed
WO-1997003045-A1 HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-01-30 — — WO disclosed
EP-0530207-A1 IMIDAZOPYRIDINE PAF ANTAGONISTS Pfizer Limited (GB) 1993-03-10 — — EP disclosed
WO-1991017162-A1 IMIDAZOPYRIDINE PAF ANTAGONISTS PFIZER LIMITED (GB) 1991-11-14 — — WO disclosed
US-4082770-A ANALGESIC, ANTIPYRETIC, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1978-04-04 — — US disclosed
US-4056526-A ANALGESIC, ANTIPYRETIC, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1977-11-01 — — US disclosed
US-4018793-A ANALGESICS, ANTIINFLAMMATORY, ANTIPYRETICS WARNER-LAMBERT COMPANY (US) 1977-04-19 — — US disclosed
US-3971814-A ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS WARNER-LAMBERT COMPANY (US) 1976-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029975-A1 1,3-BENZOTHIAZINONE DERIVATIVE AND USE THEREOF MIF, CCL2, MSR1 ABL1 1862/4885NR4A2 527/4885SLC6A4 1898/4885
US-20090192213-A1 Benzo[b]furane And Benzo[b]thiophene Derivatives CYP1B1, TBCB, CYP4B1 ABL1 331/4885NR4A2 485/4885SLC6A4 692/4885
US-20100234363-A1 HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 DATA-HYDROXYSTEROID DEHYDROGENASE HSD11B1, HSD11B2, HSD3B1 ABL1 4327/4885NR4A2 3283/4885SLC6A4 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.